Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18 (Science Daily)
Women’s responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, scientists report.
View original here:
Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18 (Science Daily)
